肠道菌群对心血管疾病患者合并焦虑抑郁影响的研究进展

doi:10.13438/j.cnki.jdzk.2021.01.013

摘要/Abstract

摘要：心血管疾病患者合并焦虑抑郁情况逐年增多，探索新的治疗模式成为热点，但在过去的心脏疾病诊疗过程中，医生较多注重器质性心脏病治疗，常常忽视了患者的心理精神问题.有大量研究表明，肠道菌群及其代谢产物不仅对防治心血管疾病具有重要作用，而且与精神心理疾病也存在密不可分的关系.本文通过综述肠道菌群及其代谢产物在双心疾病的发生、进展中的作用和机制，以及在双心疾病防治方面的潜在价值，以期为双心疾病的防治提供新思路.

关键词： 肠道菌群, 代谢产物, 双心疾病

Abstract: Psycho-cardiology refers to cardiovascular disease with mental illness which is attracted growing attention with medical development. In the previous treatment of cardiovascular disease, doctors focused more on organic cardiopathy than on psychological disease of patients. Numerous studies have shown that intestinal flora and its metabolites played a vital role not only in cardiovascular disease, but also in mental and psychological diseases. This article summarizes the influences and mechanism of intestinal flora and its metabolites in the outbreak and development of psycho-cardiology, as well as the potential value in the prevention and treatment of psycho-cardiology to offer new insights into the prevention and treatment of ppsycho-cardiology.

Key words: intestinal flora, metabolites, psycho-cardiological

薛炳清, 李春艳, 朱灿. 肠道菌群对心血管疾病患者合并焦虑抑郁影响的研究进展[J]. 吉首大学学报（自然科学版）, 2021, 42(1): 83-89.

XUE Bingqing, LI Chunyan, ZHU Can. Research Progress in the Relationship Between Intestinal Flora and Its Metabolites and Psycho-Cardiology[J]. Journal of Jishou University(Natural Sciences Edition), 2021, 42(1): 83-89.

参考文献

[1] VOS T, ABAJOBIR A A, ABATE K H, et al. Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016[J]. The Lancet, 2017, 390(10100): 1211-1259.
[2] TUNG YI-JUNG, LO KENNETH K H, HO ROGER C M, et al. Prevalence of Depression Among Nursing Students: A Systematic Review and Meta-Analysis[J]. Nurse Education Today, 2018, 63: 119-129.
[3] XU Dandan, RAO Wenwang, CAO Xiaolan, et al. Prevalence of Depressive Symptoms in Primary School Students in China: A Systematic Review and Meta-Analysis[J]. Journal of Affective Disorders, 2020, 268: 20-27.
[4] MALHI G S, MANN J J. Depression[J]. The Lancet, 2018, 392(24): 2299-2312.
[5] KELLY J R, CLARKE G, CRYAN J F, et al. Brain-Gut-Microbiota Axis: Challenges for Translation in Psychiatry[J]. Annals of Epidemiology, 2016, 26(5): 366-372.
[6] GLENWRIGHT A J, POTHULA K R, BHAMIDIMARRI S P, et al. Structural Basis for Nutrient Acquisition by Dominant Members of the Human Gut Microbiota[J]. Nature, 2017, 541(7637): 407-411.
[7] VANDANA U K, BARLASKAR N H, GULZAR A B M, et al. Linking Gut Microbiota with the Human Diseases[J]. Bioinformation, 2020, 16(2): 196-208.
[8] JIA Qiujin, LI Hao, ZHOU Huan, et al. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure[J]. Cardiovascular Therapeutics, 2019: 5164298.
[9] ROBLES A V, GUARNER F. Linking the Gut Microbiota to Human Health[J]. British Journal of Nutrition, 2013, 109(S2): S21-S26.
[10] BROWN J M, HAZEN S L. The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases[J]. Annual Review of Medicine, 2015, 66(1): 343-359.
[11] DE OLIVEIRA G L V, LEITE A Z, HIGUCHI B S, et al. Intestinal Dysbiosis and Probiotic Applications in Autoimmune Diseases[J]. Immunology, 2017, 152(1): 1-12.
[12] RHEE S H, POTHOULAKIS C, MAYER E A. Principles and Clinical Implications of the Brain-Gut-Enteric Microbiota Axis[J]. Nature Reviews Gastroenterology & Hepatology, 2009, 6(5): 306-314.
[13] BIENENSTOCK J, COLLINS S. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Psycho-Neuroimmunology and the Intestinal Microbiota: Clinical Observations and Basic Mechanisms[J]. Clinical & Experimental Immunology, 2010, 160(1): 85-91.
[14] ZHU Weifei, GREGORY J C, ORG E, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[J]. Cell, 2016, 165(1): 111-124.
[15] SCHOKKER D, FLEDDERUS J, JANSEN R, et al. Supplementation of Fructooligosaccharides to Suckling Piglets Affects Intestinal Microbiota Colonization and Immune Development[J]. Journal of Animal Science, 2018, 96(6): 2139-2153.
[16] ADIBFAR A, SALEEM M, LANCTOT K L, et al. Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review[J]. Current Molecular Medicine, 2016, 16(2): 137-164.
[17] VOGELZANGS N, BEEKMAN A T F, MILANESCHI Y, et al. Urinary Cortisol and Six-Year Risk of All-Cause and Cardiovascular Mortality[J]. The Journal of Clinical Endocrinology & Metabolism, 2010, 95(11): 4959-4964.
[18] O'MAHONYS M, MARCHESIJ R, SCULLYP, et al. Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses[J]. Biological Psychiatry, 2009, 65(3): 263-267.
[19] THEOHARIDES T C, ASADI S, PATELA B. Focal Brain Inflammation and Autism[J]. Journal of Neuroinflammation, 2013, 10(1): 46-52.
[20] BERCIK P, COLLINS S M. The Effects of Inflammation, Infection and Antibiotics on the Microbiota-Gut-Brain Axis[J]. Advances in Experimental Medicine and Biology, 2014, 817: 279-289.
[21] KHANDAKER G M, PEARSON R M, ZAMMIT S, et al. Association of Serum Interleukin 6 and C-Reactive Protein in Childhood with Depression and Psychosis in Young Adult Life[J]. JAMA Psychiatry, 2014, 71(10): 1121-1128.
[22] AIT-BELGNAOUI A, DURAND H, CARTIER C, et al. Prevention of Gut Leakiness by a Probiotic Treatment Leads to Attenuated HPA Response to an Acute Psychological Stress in Rats[J]. Psychoneuroendocrinology, 2012, 37(11): 1885-1895.
[23] LUNA R A, FOSTER J A. Gut Brain Axis: Diet Microbiota Interactions and Implications for Modulation of Anxiety and Depression[J]. Current Opinion in Biotechnology, 2015, 32: 35-41.
[24] LI Yunwei, ZHONG Xiaoming, CHENG Guanchang, et al. Hs-CRP and All-Cause, Cardiovascular, and Cancer Mortality Risk: A Meta-Analysis[J]. Atherosclerosis, 2017, 259: 75-82.
[25] FETISSOV S O. Role of the Gut Microbiota in Host Appetite Control: Bacterial Growth to Animal Feeding Behaviour[J]. Nature Reviews Endocrinology, 2017, 13(1): 11-25.
[26] BARRETTE, ROSSRP, O'TOOLEPW, et al. γ-Aminobutyric Acid Production by Culturable Bacteria from the Human Intestine[J]. Journal of Applied Microbiology, 2012, 113(2): 411-417.
[27] BRAVO J A, FORSYTHE P, CHEW M V, et al. Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression in a Mouse via the Vagus Nerve[J]. Proceedings of the National Academy of Sciences, 2011, 108(38): 16050-16055.
[28] 刘梅颜,刘舰洋,张丽军.骨髓源间充质干细胞治疗双心疾病的可行性分析[J].中华内科杂志,2019,58(12):924-928.
[29] LIANG S, WANG T, HU X, et al. Administration of Lactobacillus Helveticus NS8 Improves Behavioral, Cognitive, and Biochemical Aberrations Caused by Chronic Restraint Stress[J]. Neuroscience, 2015, 310: 561-577.
[30] SUBEDI L, HUANG Hong, PANT A, et al. Plasma Brain-Derived Neurotrophic Factor Levels in Newborn Infants with Neonatal Abstinence Syndrome[J]. Frontiers in Pediatrics, 2017, 5: 238-244.
[31] PREMYSL B, EMMANUEL D, JOSH C, et al. The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice[J]. Gastroenterology, 2011, 141(2): 599-609.
[32] MCCAFFERY J M, DUANQingling, FRASURE-SMITH N, et al. Genetic Predictors of Depressive Symptoms in Cardiac Patients[J]. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009, 150B(3): 381-388.
[33] ROMANO K A, VIVAS E I, AMADOR-NOGUEZ D, et al. Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide[J]. Mbio, 2015, 6(2): e02481-14.
[34] TANG WH W, KITAI T, HAZEN S L. Gut Microbiota in Cardiovascular Health and Disease[J]. Circulation Research, 2017, 120(7): 1183-1196.
[35] NAGATOMO Y, TANG W H W. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis[J]. Journal of Cardiac Failure, 2015, 21(12): 973-980.
[36] PASINIE, AQUILANIR, TESTAC, et al. Pathogenic Gut Flora in Patients with Chronic Heart Failure[J]. JACC: Heart Failure, 2016, 4(3): 220-227.
[37] SANDEK A, SWIDSINSKI A, SCHROEDL W, et al. Intestinal Blood Flow in Patients with Chronic Heart Failure: A Link with Bacterial Growth, Gastrointestinal Symptoms, and Cachexia[J]. Journal of the American College of Cardiology, 2014, 64(11): 1092-1102.
[38] NEVES A L, COELHO J, COUTO L, et al. Metabolic Endotoxemia: A Molecular Link Between Obesity and Cardiovascular Risk[J]. Journal of Molecular Endocrinology, 2013, 51(2): R51-R64.
[39] TRSEID M, UELAND T, HOV J R, et al. Microbiota-Dependent Metabolite Trimethylamine-N-Oxide is Associated with Disease Severity and Survival of Patients with Chronic Heart Failure[J]. Journal of Internal Medicine, 2015, 277(6): 717-726.
[40] HEIANZA Y, MA Wenjie, MANSON J E, et al. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies[J]. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017, 6(7): e004947.
[41] SUZUKI T, YAZAKIY, VOORSA A, et al. Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHF[J]. European Journal of Heart Failure, 2019, 21(7): 877-886.
[42] SOLAK Y, AFSAR B, VAZIRI ND, et al. Hypertension as an Autoimmune and Inflammatory Disease[J]. Hypertension Research, 2016, 39(8): 567-573.
[43] KARBACH S H, SCHNFELDER T, BRANDO I, et al. Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction[J]. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016, 5(9): e003698.
[44] QI Yanfei, ARANDA J M, RODRIGUEZ V, et al. Impact of Antibiotics on Arterial Blood Pressure in a Patient with Resistant Hypertension—A Case Report[J]. International Journal of Cardiology, 2015, 201: 157-158.
[45] ZAMPARELLI M S, COMPARE D, COCCOLI P, et al. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease[J]. International Journal of Molecular Sciences, 2016, 17(8): 1225-1235.
[46] CHIOU V L, BUROTTO M. Pseudoprogression and Immune-Related Response in Solid Tumors[J]. Journal of Clinical Oncology, 2015, 33(31): 3541-3543.
[47] GEORGE S, MOTZER R J, HAMMERS H J, et al. Safety and Efficacy of Nivolumab in Patients with Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial[J]. JAMA Oncology, 2016, 2(9): 1179-1186.
[48] 赵乐恒,吕昌龙,孙洪涛.肠道菌群和黏膜免疫与心血管疾病关系研究新进展[J].中国免疫学杂志,2018,34(9):1433-1436;1441.
[49] CURTISS L K, TOBIAS P S. Emerging Role of Toll-Like Receptors in Atherosclerosis[J]. The Journal of Lipid Research, 2008, 50(Suppl 1): S340-S345.
[50] WANG Zeneng, KLIPFELL E, BENNETTB J, et al. Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease[J]. Nature, 2011, 472(7341): 57-63.
[51] KOREN O, SPOR A, FELIN J, et al. Human Oral, Gut, and Plaque Microbiota in Patients with Atherosclerosis[J]. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(Suppl 1): 4592-4598.
[52] LE CHATELIER E, NIELSEN T, QIN Junjie, et al. Richness of Human Gut Microbiome Correlates with Metabolic Markers[J]. Nature, 2013, 500(7464): 541-546.
[53] ZHAO Liping. The Gut Microbiota and Obesity: From Correlation to Causality[J]. Nature Reviews Microbiology, 2013, 11(9): 639-647.
[54] CANI P D, BIBILONI R, KNAUF C, et al. Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice[J]. Diabetes, 2008, 57(6): 1470-1481.
[55] QIN Junjie, LI Yingrui, CAI Zhiming, et al. A Metagenome-Wide Association Study of Gut Microbiota in Type 2 Diabetes[J]. Nature, 2012, 490(7418): 55-60.
[56] KARLSSON F H, TREMAROLI V, NOOKAEW I, et al. Gut Metagenome in European Women with Normal, Impaired and Diabetic Glucose Control[J]. Nature, 2013, 498(7452): 99-103.
[57] ANDREASENA S, LARSENN, PEDERSEN-SKOVSGAARDT, et al. Effects of Lactobacillus Acidophilus NCFM on Insulin Sensitivity and the Systemic Inflammatory Response in Human Subjects[J]. British Journal of Nutrition, 2010, 104(12): 1831-1838.
[58] VRIEZE A, NOOD E V, HOLLEMAN F, et al. Transfer of Intestinal Microbiota from Lean Donors Increases Insulin Sensitivity in Individuals with Metabolic Syndrome[J]. Gastroenterology, 2012, 143(4): 913-916.
[59] RYAN K K, TREMAROLI V, CLEMMENSEN C, et al. FXR is a Molecular Target for the Effects of Vertical Sleeve Gastrectomy[J]. Nature, 2014, 509(7499): 183-188.
[60] WARRIER M, SHIHD M, BURROWSA C, et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 is a Central Regulator of Cholesterol Balance[J]. Cell Reports, 2015, 10(3): 326-338.
[61] 李超,崔立红.高脂血症、高脂饮食与肠道菌群的关系[J].世界华人消化杂志,2013,21(14):1273-1277.
[62] FU Jingyuan, BONDER M J, CENIT M C, et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids[J]. Circulation Research, 2015, 117(9): 817-824.